250.03  3.01 (1.22%)		07-16 14:04
Open: 248.9 High: 253.545 Volume: 4,744,902		Pre. Close: 247.02 Low: 246.28 Market Cap: 601,877(M)

Short term
Mid term
Targets	6-month :	314.69	1-year :	367.56
Resists	First :	269.42	Second :	314.69
Pivot price	256.21
Supports	First :	243.51	Second :	227.5
MAs	MA(5) :	253.03	MA(20) :	250.86
	MA(100) :	237.24	MA(250) :	210.69
MACD	MACD :	4.8	Signal :	6.3
%K %D	K(14,3) :	37.6	D(3) :	51.7
RSI	RSI(14): 51.3
52-week	High :	269.42	Low :	158.81

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ JNJ ] has closed above bottom band by 21.8%. Bollinger Bands are 32.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	257.33 - 258.79	258.79 - 260.37
Low:	242.08 - 243.67	243.67 - 245.39
Close:	244.03 - 246.79	246.79 - 249.78

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Thu, 16 Jul 2026
Johnson preps to punt government funding through midterms - Politico

Thu, 16 Jul 2026
The Real Engine Behind Johnson & Johnson Stock’s Next Climb - Trefis

Thu, 16 Jul 2026
Pilot injured after helicopter crash in Johnson County - KCRG

Thu, 16 Jul 2026
Eagles 2026 most important list: Lane Johnson - NBC Sports Philadelphia

Wed, 15 Jul 2026
Johnson & Johnson CFO Says Guidance Hike Is Just the Start - Barron's

Wed, 15 Jul 2026
Johnson unveils $95 billion plan for Iran war, election grants and farm aid - CNN

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Healthcare
Industry: Drug Manufacturers - General
Shares Out	2,410 (M)
Shares Float	2,400 (M)
Held by Insiders	0 (%)
Held by Institutions	76.8 (%)
Shares Short	26,580 (K)
Shares Short P.Month	23,410 (K)

EPS	8.63
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	33.74
Profit Margin	21.8 %
Operating Margin	27.4 %
Return on Assets (ttm)	8.4 %
Return on Equity (ttm)	26.4 %
Qtrly Rev. Growth	9.8 %
Gross Profit (p.s.)	27.2
Sales Per Share	39.98
EBITDA (p.s.)	14.24
Qtrly Earnings Growth	-53 %
Operating Cash Flow	22,870 (M)
Levered Free Cash Flow	12,510 (M)

PE Ratio	28.91
PEG Ratio	5
Price to Book value	7.39
Price to Sales	6.24
Price to Cash Flow	26.29

Dividend	1.34
Forward Dividend	0
Dividend Yield	0.5%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.